Dear colleagues, welcome to meeting No. 4 of the Standing Committee on Foreign Affairs and International Development.
Pursuant to the motion adopted on January 31, the committee is meeting on its study of vaccine equity and intellectual property rights.
As always, interpretation is available at this meeting. To listen to the interpretation, just click on the globe icon at the bottom of your screen.
I would ask members participating in person to keep in mind the Board of Internal Economy's guidelines for mask wearing and health protocols.
I'd like to take the opportunity to remind all participants that screenshots and taking photos of your screen are not permitted.
Before speaking, please wait until I recognize you by name. When speaking, please speak slowly and clearly. When you are not speaking, your mic should be on mute.
A reminder that all comments by members and witnesses should be addressed through the Chair.
Colleagues, I would like to now welcome our first panel of witnesses before the committee and thank them for agreeing to spend time with us this morning.
As usual, when you have 30 seconds remaining in your testimony or questioning time, I will signal you with this yellow piece of paper, so please keep an eye on your screens.
I would now like to welcome this morning's first panel of witnesses.
First, we welcome France‑Isabelle Langlois, Executive Director of Amnistie internationale Canada francophone.
From Oxfam Canada, we have Diana Sarosi, director, policy and campaigns; and Brittany Lambert, women's rights policy and advocacy specialist.
You'll each have five minutes for your opening statements.
I propose that we start with Ms. Langlois.
Ms. Langlois, you have five minutes for your opening statement.